NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Structured Abstract
Objectives:
We reviewed the evidence on the barriers and drivers to the use of interactive consumer health information technology (IT) by specific populations, namely the elderly, those with chronic conditions or disabilities, and the underserved.
Data Sources:
We searched MEDLINE®, CINHAHL®, PsycINFO®, the Cochrane Controlled Trials Register and Database of Systematic Reviews, ERIC, and the American Association of Retired Persons (AARP) AgeLine® databases. We focused on literature 1990 to present.
Methods:
We included studies of all designs that described the direct use of interactive consumer health IT by at least one of the populations of interest. We then assessed the quality and abstracted and summarized data from these studies with regard to the level of use, the usefulness and usability, the barriers and drivers of use, and the effectiveness of the interactive consumer health IT applications.
Results:
We identified and reviewed 563 full-text articles and included 129 articles for abstraction. Few of the studies were specifically designed to compare the elderly, chronically ill, or underserved with the general population. We did find that several types of interactive consumer health IT were usable and effective in multiple settings and with all of our populations of interest. Of the studies that reported the impact of interactive consumer health IT on health outcomes, a consistent finding of our review was that these systems tended to have a positive effect when they provided a complete feedback loop that included (a) monitoring of current patient status, (b) interpretation of this data in light of established, often individualized, treatment goals, (c) adjustment of the management plan as needed, (d) communication back to the patient with tailored recommendations or advice, and (e) repetition of this cycle at appropriate intervals. Systems that provided only one or a subset of these functions were less consistently effective.
The barriers and drivers to use were most often reported as secondary outcomes. Many studies were hampered by usability problems and unreliable technology, primarily due to the research being performed on early stage system prototypes. However, the most common factor influencing the successful use of the interactive technology by these specific populations was that the consumers' perceived a benefit from using the system. Convenience was an important factor. It was critical that data entry not be cumbersome and that the intervention fit into the user's daily routine. Usage was more successful if the intervention could be delivered on technology consumers used every day for other purposes. Finally, rapid and frequent interactions from a clinician improved use and user satisfaction.
Conclusions:
The systems described in the studies we examined depended on the active engagement of consumers and patients and the involvement of health professionals, supported by the specific technology interventions. Questions remain as to (a) the optimal frequency of use of the system by the patient, which is likely to be condition-specific; (b) the optimal frequency of use or degree of involvement by health professionals; and (c) whether the success depends on repeated modification of the patient's treatment regimen or simply ongoing assistance with applying a static treatment plan. However, it is clear that the consumer's perception of benefit, convenience, and integration into daily activities will serve to facilitate the successful use of the interactive technologies for the elderly, chronically ill, and underserved.
Contents
- Preface
- Acknowledgments
- Executive Summary
- 1. Introduction
- 2. Methods
- 2. a. Technical Expert Panel Input
- 2. b. Key Questions and Analytic Framework
- 2. c. Population
- 2. d. Technology
- 2. d. i. Further Refinement of Technologies
- 2. e. Outcomes
- 2. f. Study Designs
- 2. g. Data Sources and Search Strategy
- 2. h. Inclusion and Exclusion of Literature
- 2. i. Data Abstraction
- 2. j. Quality Rating of Studies
- 2. k. Data Synthesis
- 2. l. Peer Review
- 3. Results
- 3. a. Findings for Key Question 1: Level of Use of Interactive Consumer Health IT
- 3. b. Findings for Key Question 2: Usefulness and Usability of Interactive Consumer Health IT
- 3. c. Findings for Key Question 3: Barriers to Use of Interactive Consumer Health IT
- 3. d. Findings for Key Question 4: Drivers and Facilitators of the Use of Interactive Consumer Health IT
- 3. e. Findings for Key Question 5: Effectiveness of Interactive Consumer Health IT
- 3. f. Specific Findings for Populations of Interest
- 4. Discussion
- 4. a. Use of Interactive Consumer Health IT
- 4. b. Usefulness and Usability of Interactive Consumer Health IT
- 4. c. Barriers to the Use of Interactive Consumer Health IT
- 4. d. Drivers to the Use of Interactive Consumer Health IT
- 4. e. Effectiveness of Interactive Consumer Health IT
- 4. f. Use of Interactive Consumer Health IT by Populations of Interest
- 4. g. Technical Difficulties Interfering With Evaluations
- 5. Future Research
- 6. Conclusions
- Summary Tables
- Appendixes
- Appendix A. Technical Expert Panel Members
- Appendix B. Search Strategies
- Appendix C. Inclusion/exclusion criteria
- Appendix D. Literature Search Tree
- Appendix E. Excluded Studies List
- Appendix F. Quality Assessment Criteria
- Appendix G. Peer Reviewers
- Appendix H. Data Abstraction Table with References
- Appendix I. Study Quality Assessment Table with References
- References
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.1 Contract No. 290-02-0024. Prepared by: Oregon Evidence-based Practice Center, Portland, Oregon.
Suggested citation:
Jimison H, Gorman P, Woods S, Nygren P, Walker M, Norris S, Hersh W. Barriers and Drivers of Health Information Technology Use for the Elderly, Chronically Ill, and Underserved. Evidence Report/Technology Assessment No. 175 (Prepared by the Oregon Evidence-based Practice Center under Contract No. 290-02-0024). AHRQ Publication No. 09-E004. Rockville, MD: Agency for Healthcare Research and Quality. November 2008.
This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0024). The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This report is intended as a reference and not as a substitute for clinical judgment.
This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
No investigators have any affilications or financial involvement (e.g., employment, consultancies, honoraria, stock options, expert testimony, grants or patents received or pending, or royalties) that conflict with material presented in this report.
- 1
540 Gaither Road, Rockville, MD 20850. www
.ahrq.gov
- Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.[Med J Aust. 2020]Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Osborne SR, Alston LV, Bolton KA, Whelan J, Reeve E, Wong Shee A, Browne J, Walker T, Versace VL, Allender S, et al. Med J Aust. 2020 Dec; 213 Suppl 11:S3-S32.e1.
- The future of Cochrane Neonatal.[Early Hum Dev. 2020]The future of Cochrane Neonatal.Soll RF, Ovelman C, McGuire W. Early Hum Dev. 2020 Nov; 150:105191. Epub 2020 Sep 12.
- Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.[Evid Rep Technol Assess (Summ)...]Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.Hersh WR, Wallace JA, Patterson PK, Shapiro SE, Kraemer DF, Eilers GM, Chan BK, Greenlick MR, Helfand M. Evid Rep Technol Assess (Summ). 2001 Aug; (24 Suppl):1-32.
- Review Consumer Health Informatics Adoption among Underserved Populations: Thinking beyond the Digital Divide.[Yearb Med Inform. 2018]Review Consumer Health Informatics Adoption among Underserved Populations: Thinking beyond the Digital Divide.Huh J, Koola J, Contreras A, Castillo AK, Ruiz M, Tedone KG, Yakuta M, Schiaffino MK. Yearb Med Inform. 2018 Aug; 27(1):146-155. Epub 2018 Aug 29.
- Review Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force[ 2020]Review Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task ForcePatnode CD, Perdue LA, Rossom RC, Rushkin MC, Redmond N, Thomas RG, Lin JS. 2020 Feb
- Barriers and Drivers of Health Information Technology Use for the Elderly, Chron...Barriers and Drivers of Health Information Technology Use for the Elderly, Chronically III, and Underserved
- Diffusion and Dissemination of Evidence-based Cancer Control InterventionsDiffusion and Dissemination of Evidence-based Cancer Control Interventions
- Post-Myocardial Infarction DepressionPost-Myocardial Infarction Depression
- Behavioral and Physical Treatments for Migraine HeadacheBehavioral and Physical Treatments for Migraine Headache
- Cancer Care Quality MeasuresCancer Care Quality Measures
Your browsing activity is empty.
Activity recording is turned off.
See more...